1-17 of 17
Weida Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and Efficacy of Selinexor Plus Bortezomib, Lenalidomide and Dexamethasone (XVRd) in High Risk Newly Diagnosed Multiple Myeloma: A Multi-Center, Single-Arm, Phase Ib/II Trial

Xiaoqin Chen, Yun Wang, Weida Wang, Hua Wang, Bingyi Wu, Yang Liang, Zhongjun Xia
Journal: Blood
Blood (2024) 144 (Supplement 1): 7025.
https://doi.org/10.1182/blood-2024-204564
Published: 2024
Journal Articles

Efficiency and Safety of Pegylated Filgrastim Combined with Plerixafor in Multiple Myeloma Autologous Hematopoietic Stem Cells Mobilization

Chenfei Liu, Yuanbin Song, Yang Liang, Lu Lu, Weida Wang, Bingyi Wu
Journal: Blood
Blood (2024) 144 (Supplement 1): 7118.
https://doi.org/10.1182/blood-2024-207526
Published: 2024
Journal Articles

Safety and Efficacy of Luspatercept in Low-Risk Myelodysplastic Neoplasms with Anaemia

Yang Liang, Yuanbin Song, Chenfei Liu, Lu Lu, Bingyi Wu, Weida Wang, Shuzhao Chen, Lezong Chen
Journal: Blood
Blood (2024) 144 (Supplement 1): 6713.
https://doi.org/10.1182/blood-2024-207749
Published: 2024
Journal Articles

Mitoxantrone Hydrochloride Liposome Combined with Cytarabine As Induction Therapy for Patients with Newly Diagnosed Secondary Acute Myeloid Leukemia

Yun Wang, Weida Wang, Jingbo Xu, Ji Ma, Hua Wang, Bingyi Wu, Yuanbin Song, Weiran Lv, Lezong Chen, Jun Ma, Tiejun Gong, Yang Liang
Journal: Blood
Blood (2024) 144 (Supplement 1): 6074.
https://doi.org/10.1182/blood-2024-209055
Published: 2024
Journal Articles

Real-World Outcome of Daratumumab in Patients with Relapsed/Refractory Multiple Myeloma: A Multicenter Propensity Score Matched Case Series Study

Weida Wang, Yaofang Hu, Yun Wang, Xiaoqin Chen, Zhongjun Xia
Journal: Blood
Blood (2022) 140 (Supplement 1): 12589–12590.
https://doi.org/10.1182/blood-2022-171132
Published: 2022
Journal Articles

Higher-Dose Donor Derived Ex Vivo Expanded Natural Killer Cell Infusion Prior to Haploidentical Stem Cell Transplantation on Acute Myeloid Leukemia: Efficacy and Safety

Weida Wang, Yang Liang, Yuanbin Song, Hanying Huang, Bingyi Wu
Journal: Blood
Blood (2022) 140 (Supplement 1): 12713.
https://doi.org/10.1182/blood-2022-169773
Published: 2022
Journal Articles

Systematic Construction of an Autophagic Risk Model in Bone Marrow for Prognostic Prediction in Multiple Myeloma

Lingling Shu, Han-Ying Huang, Yang Liu, Yang Li, Weida Wang, Jinyuan Li, Shuzhao Chen, Xiaoping Wu, Yun Wang, Huan-xin Lin, Yang Liang
Journal: Blood
Blood (2021) 138 (Supplement 1): 4713.
https://doi.org/10.1182/blood-2021-150454
Published: 2021
Journal Articles

Ixazomib Based Maintenance Therapy for the Patients with Newly Diagnosed Multiple Myeloma in Real-World Practice

Liye Zhong, Yongqiang Wei, Baohong Ping, Xin Li, Hongling Peng, Yongqain Li, Yuyang Tian, Zelin Liu, Jun Luo, Yongzhong Su, Haifei Chen, Yanjuan He, Hongliang Li, Congming Wu, Zhiqiang Sun, Keqian Shi, Xiaoliang Li, Qing Zhang, Guoyu Hu, Gang Huang, Zhenqian Huang, Weida Wang, Zhongjun Xia
Journal: Blood
Blood (2021) 138 (Supplement 1): 2718.
https://doi.org/10.1182/blood-2021-149058
Published: 2021
Journal Articles

Bone Marrow Adipocyte Promotes Epithelial-Mesenchymal-Transition-like Activation in Multiple Myeloma Via CXCL-12/CXCR4 Axis

Ling-Ling Shu, Shuzhao Chen, Jinyuan Li, Weida Wang, Yang Liu, Yang Li, Han-Ying Huang, Xiaoping Wu, Yang Liang
Journal: Blood
Blood (2021) 138 (Supplement 1): 1584.
https://doi.org/10.1182/blood-2021-152400
Published: 2021
Journal Articles

Development and Validation of a Risk Assessment Model for Early Infection during the First 3 Months in Patients with Newly Diagnosed Multiple Myeloma

Yufeng Shang, Weida Wang, MD PhD, Minghui Liu, Xiaoqin Chen, MDPhD, Zhongjun Xia, MDPhD, Fuling Zhou, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 29–30.
https://doi.org/10.1182/blood-2020-141735
Published: 2020
Journal Articles

An Accurate Prognostic Survival Model of Survival Based on Expression of Genes Involved in Plasma Cell Metabolism

Yang Liang, MD, Han-ying Huang, Yun Wang, MD PhD, Weida Wang, MD PhD, Jin-Yuan Li, Ling-ling Shu
Journal: Blood
Blood (2020) 136 (Supplement 1): 14–15.
https://doi.org/10.1182/blood-2020-140930
Published: 2020
Journal Articles

A Phase 1 Dose-Escalation Study of LH031, a Kinesin Spindle Protein Inhibitor, in Patients with Refractory/Resistance Multiple Myeloma

Zhongjun Xia, MDPhD, Su Li, Xiaoqin Chen, MDPhD, Weida Wang, MD PhD, Yan Song
Journal: Blood
Blood (2020) 136 (Supplement 1): 37.
https://doi.org/10.1182/blood-2020-137346
Published: 2020
Journal Articles

An Immune Score Model of the Bone Marrow Micro-Environment Predicts Survival in Chronic Lymphocytic Leukaemia

Yang Liang, MD, Han-ying Huang, Yun Wang, MD PhD, Weida Wang, MD PhD, Huan-xin Lin
Journal: Blood
Blood (2020) 136 (Supplement 1): 38.
https://doi.org/10.1182/blood-2020-140925
Published: 2020
Journal Articles

Adipocyte Fatty Acid Binding Protein Promotes Multiple Myeloma through Regulating Bone Marrow Microenvironment

Lingling Shu, MD PhD, Jinyuan Li, Weida Wang, MD PhD, Xiaoping Wu, PhD, Hanying Huang, Fang Hu, Yang Liang, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 31–32.
https://doi.org/10.1182/blood-2020-140732
Published: 2020
Journal Articles

Identification of an Immune Risk Score to Predict the Prognosis of Acute Myeloid Leukemia

Yang Liang, PhD, Yun Wang, Yan-Yu Cai, Siliang Chen, Run-Cong Nie, Zhe-Yuan Qin, PhD, Fang Hu, Weida Wang, MD, Yu-Jun Dai, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 708.
https://doi.org/10.1182/blood-2019-126733
Published: 2019
Journal Articles

The Efficacy and Safety Profile of Ixazomib-Based Regimens in Patients with Relapsed/Refractory Multiple Myeloma in Routine Clinical Practice: Real World Data from a Multi-Center Study in China

Jing Li, MD, Li Bao, Zhong-jun Xia, MD, Kaiyang Ding, Bingzong Li, MD PhD, Bing Chen, Zhengzheng Fu, Sili Wang, Wenhao Zhang, MD PhD, Xin Zhou, Luoming Hua, PhD, Wei Yang, Luo Jun, Liang Wang, Tianhong Xu, Yang Yang, Weida Wang, MD, Guolin Wu, Yun Huang, Peng Liu, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5592.
https://doi.org/10.1182/blood-2019-130040
Published: 2019
Journal Articles

Ixazomib-Based Frontline Therapy in Patients with Newly Diagnosed Multiple Myeloma in Real-Life Practice Showed Comparable Efficacy and Safety Profile with Those Reported in Randomized Clinical Trials: A Multi-Center Study in China

Jing Li, MD, Li Bao, Zhong-jun Xia, MD, Sili Wang, Xin Zhou, Kaiyang Ding, Wenhao Zhang, MD PhD, Wei Yang, Bingzong Li, MD PhD, Zhengzheng Fu, Bing Chen, Luoming Hua, PhD, Liang Wang, Luo Jun, Yang Yang, Tianhong Xu, Weida Wang, MD, Yun Huang, Guolin Wu, Peng Liu, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3181.
https://doi.org/10.1182/blood-2019-128614
Published: 2019